Revolutionising
Paediatric Research

Innovative clinical trials without the administrative burden. Elixir AI empowers paediatric doctors to effortlessly design, conduct, and analyse studies while reducing waiting lists and costs.

Explore Active Studies
A Streamlined Research Journey

From Idea to Impact in Four Simple Steps

Effortless Trial Design

Transform your research concepts into fully-fledged trials using our intuitive authoring tools, complete with automated regulatory compliance checks.

Seamless Recruitment

Digitally enroll participants and obtain informed consent through our secure platform, reaching diverse populations with ease.

Remote Data Collection

Gather valuable insights through user-friendly digital forms, reducing in-person visits and increasing participant engagement.

Actionable Insights

Leverage our AI-powered analytics to uncover patterns, segment patients, and translate findings into improved care strategies.

Join An Active Study
Mission
About Us

Empowering Paediatric Innovation

Elixir AI is revolutionising paediatric research by removing barriers and fostering innovation. Our platform enables doctors to conduct meaningful studies without the traditional burdens of paperwork and high costs. By bridging the gap between clinical practice and cutting-edge research, we're accelerating the path to better child health outcomes.

Why Elixir AI?

Cost-Effective
Our platform is free for doctors, with any grant funding shared between the collaborators.

Precision Medicine
Easily segment patients by severity, disease, or physiological traits to tailor treatments and improve outcomes.

Fast Implementation
Test ideas to reduce waiting lists and departmental costs, turning your insights into actionable improvements.

Collaborative Network
Join a community of forward-thinking paediatricians, plus connect with parents and scientists to amplify your research impact.

Frequently Asked Questions

Elixir AI is completely free for paediatric doctors. Elixir collaborates with you in the project and shares any grant money, ensuring there's no upfront cost to you.


Absolutely! Our platform is designed to enable research without the need for traditional grant funding. You can start a pilot single site study quicker than you thought to obtain data. If you have a colleague with a similar interest in a different hospital, you have a multi-site study.


We do the heavy lifting with the required documents and our platform includes built-in compliance checks and automated processes to ensure your study meets all necessary regulatory requirements, significantly reducing the paperwork burden.


Our digital recruitment and consent features allow you to easily reach potential participants and obtain informed consent through a secure, user-friendly interface.


Absolutely. We adhere to the highest standards of data security. Patient data is encrypted in transit and at rest. Elixir complies with all relevant data protection regulations, including GDPR.


Yes! Elixir AI facilitates collaboration between doctors, parents, and university or industry scientists, allowing you to expand the scope and impact of your research.


Elixir could assist as much or as little as you need. If required we can provide powerful AI-driven analytics tools that can help you identify patterns, segment patients, and generate insights from the collected data.


Yes, Elixir AI is ideal for post-market approval studies. We offer paid services for pharmaceutical and biotech companies specifically for this purpose.


Unlike CROs, Elixir AI enables direct sponsorship of studies, reducing costs and delays associated with outsourced research. We specialise in paediatric trials and leverage advanced technology to enhance research processes.

Have any questions?

We are here to help! Whether you have questions about a research study, need support, or want to learn more about how Elixir could benefit you, feel free to reach out to us.

Contact Us